当前位置:主页 > 医学论文 > 外科论文 >

倍他米松与医用生物蛋白胶在腰椎神经根减压术中的联合应用评价

发布时间:2018-06-10 09:55

  本文选题:倍他米松 + 医用生物蛋白胶 ; 参考:《中国医院药学杂志》2017年08期


【摘要】:目的:评价在神经根减压术中联合应用倍他米松和医用生物蛋白胶的疗效。方法:观察对象为腰椎神经根减压术术后的120例患者,根据术后处理方式的不同将患者分为4组:A组单纯手术组,B组单纯应用倍他米松组,C组单纯应用医用生物蛋白胶组,D组倍他米松联合应用医用生物蛋白胶组。观察各组术后直腿抬高试验角度、改良JOA评分、ODI评分、VAS评分、术后48 h内引流量,分析各组检查结果的差异。结果:术前患者年龄、病史时程、男女比例、直腿抬高试验角度、改良JOA评分、ODI评分、VAS评分、术后48 h内引流量均无统计学意义。术后各组患者直腿抬高试验角度在不同时期均有明显改善,差异有统计学意义(P0.05)。术后4周,D组患者髋关节运动角度显著高于其他3组,差异有统计学意义[(75±23)°vs.(54±19)°,vs.(62±20)°,vs.(64±21)°,(P0.05)];术后4周,D组患者膝关节运动角度显著低于其他3组,差异有统计学意义[(11±4)°vs.(16±6)°,vs.(13±5)°,vs.(14±5)°,(P0.05)];术后4周,D组患者髋关节运动角度显著高于A组,差异有统计学意义[(74±21)°vs.(54±19)°,(P0.05)]。术后患者症状也有显著改善:术后4周,D组患者改良JOA评分显著高于其他3组,差异有统计学意义[(22±7)vs.(16±6),vs.(18±5),vs.(18±5),(P0.05)]。术后4周,D组患者ODI评分显著低于其他3组,差异有统计学意义[(9±2)vs.(18±3),vs.(13±2),vs.(15±3),(P0.05)]。D组患者VAS评分显著低于其他3组,差异有统计学意义[(3.3±0.6)vs.(5.4±0.8),vs.(4.3±0.7),vs.(4.2±0.7),(P0.05)]。D组患者术后48 h内引流量明显低于其他3组,差异有统计学意义[(316±41)vs.(457±51),vs.(420±56),vs.(391±48),(P0.05)]。结论:联合应用倍他米松和医用生物蛋白胶能够在神经根减压术中收获比单用药物更好的疗效。
[Abstract]:Objective: to evaluate the efficacy of betamethasone and biomedical bioprotein glue in nerve root decompression. Methods: 120 cases of lumbar nerve root decompression were observed. The patients were divided into 4 groups according to the different ways of treatment after operation. The patients were divided into 4 groups: group B and group B were treated with betamethasone alone, group C was treated with betamethasone alone, group D was treated with betamethasone combined with medical bioprotein glue. The straight leg elevation test angle, modified JOA score and ODI score and VAS score were observed in each group. The drainage flow was observed within 48 hours after operation, and the difference of examination results in each group was analyzed. Results: there was no significant difference in preoperative age, history duration, male to female ratio, straight leg elevation test angle, improved JOA score and ODI score and VAS score. There was no significant difference in drainage volume within 48 hours after operation. The angle of straight leg elevation test was significantly improved in each group after operation, and the difference was statistically significant (P 0.05). 4 weeks after operation, the motion angle of hip joint in group D was significantly higher than that in the other three groups, and the difference was statistically significant [75 卤23 掳vs.(54 卤19 掳/ vs.62 卤20 掳/ vs.64 卤21 掳P0.05], and the motor angle of knee joint in group D was significantly lower than that in the other three groups at 4 weeks after operation, and the motion angle of knee joint in group D was significantly lower than that in group D at 4 weeks after operation. The difference was statistically significant [11 卤4 掳vs.(16 卤6 掳vs.13 卤5 掳vs.14 卤5 掳P0.05], and the motion angle of hip joint in group D was significantly higher than that in group A 4 weeks after operation [74 卤21 掳vs.(54 卤19 掳P0.05]. The modified 7)vs.(16 scores in group D were significantly higher than those in the other three groups at 4 weeks after operation (P < 0.05). At 4 weeks after operation, the ODI scores of group D were significantly lower than those of the other three groups, and the difference was statistically significant [9 卤2)vs.(18 卤3ovs.13 卤2ovs.15 卤3 + P0.05] .VAS score of group D was significantly lower than that of the other three groups (3.3 卤0.6)vs.(5.4 卤0.8vs.4.3 卤0.7vs.f.42 卤0.7). The drainage volume in group D was significantly lower than that in the other three groups within 48 hours after operation, and there was a significant difference between group D and group D (P < 0.05), and there was a significant difference between group D and group D (P < 0.05), and the difference was significant (P < 0.05), and there was a significant difference between group D and group D (P < 0.05). The difference was statistically significant [316 卤41)vs.(457 卤51ovs.f.420 卤56ovs.391卤 48P0.05]. Conclusion: combined use of betamethasone and biomedical bioprotein glue is more effective than single drug in nerve root decompression.
【作者单位】: 承德医学院附属医院脊柱外一科;
【分类号】:R687.3

【相似文献】

相关期刊论文 前10条

1 刘首记;王湛;;医用生物蛋白胶应用于甲状腺次全切除术的意义[J];现代生物医学进展;2007年09期

2 李智佳;章海波;黄壮荣;马庆荣;陈凯;;医用生物蛋白胶在体外循环心脏直视手术中止血的应用体会[J];现代生物医学进展;2010年08期

3 李寅,何兆群;医用生物蛋白胶在甲状腺次全切除术中的应用[J];广东医学;2005年02期

4 赵晔;谷天祥;喻磊;张玉海;王春;;喷涂医用生物蛋白胶减少心包大部剥脱患者术后渗血[J];中国组织工程研究与临床康复;2007年13期

5 杨庆华,庄洪兴,何素霞,张海明,程宏伟,何乐人,韩娟,赵延勇;医用生物蛋白胶应用于扩张器置入时的临床研究[J];中华整形外科杂志;2001年06期

6 叶方;兰树华;应锦河;吕国强;吴泉州;;医用生物蛋白胶治疗骶管囊肿[J];中国骨伤;2008年01期

7 庄熙晶;何学志;张庆华;梁永才;;医用生物蛋白胶在冠状动脉旁路移植手术中的应用[J];中外医疗;2010年11期

8 张艳春;李国祥;杨晓飞;;医用生物蛋白胶在腹腔镜胆囊切除术中的应用[J];贵阳中医学院学报;2007年04期

9 杜大军;尚长海;丁小崇;;医用生物蛋白胶在预防乳腺癌术后并发症中的应用价值[J];河南外科学杂志;2008年03期

10 孙明举,周勇刚,唐佩福,孙庆元,麻滨瑞,廖轶铭,蒋冬平;医用生物蛋白胶注射治疗复发性腕与乆窝部囊肿19例报告[J];中国实用外科杂志;2001年04期

相关会议论文 前1条

1 高原;赵逵;龙小英;熊弦;;胃镜下医用生物蛋白胶封堵治疗食管瘘[A];2008年贵州省医学会消化及内镜学分会学术大会论文汇编[C];2008年

相关博士学位论文 前1条

1 周迎春;局部应用医用生物蛋白胶缓释神经生长因子对损伤视神经和视网膜节细胞保护作用的实验研究[D];华中科技大学;2005年

相关硕士学位论文 前1条

1 庞广兴;椎体内注射医用生物蛋白胶对松质骨创面出血的实验研究[D];南方医科大学;2009年



本文编号:2002810

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/waikelunwen/2002810.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户af501***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com